Trial Profile
Multicenter Randomized Controlled Study of Rosuvastatin for Prevention of Contrast Induced Acute Kidney Injury in Patients With Diabetes and Slight to Moderate Renal Insufficient
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Mar 2014
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Acute kidney injury
- Focus Therapeutic Use
- Acronyms TRACK-D
- 28 Mar 2014 New trial record
- 01 Nov 2011 Primary endpoint 'Serum-creatinine-levels' has been met.